Comments to FDA: Psyllium Share page: Docket Number: 78N-036L Letter to Charles Ganley, M.D. regarding the agency's determination and comments pertaining to psyllium. Download Document Issues: OTC Medicines Other Issues Quality Related Posts Regulation of OTC Medicines Press Releases and Statements CHPA Congratulates Dr. Doug Bierer as First Recipient of the William Cooley Regulatory & Scientific Affairs Career Achievement Award Sep 18, 2024 Press Releases and Statements Health In Hand Foundation Announces 2024 U.S. Self-Care Marketing Awards Finalists Sep 9, 2024